ELTX Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 июнь 2024 @ 20:51):
Our systems believe the stock currently is undervalued by 0.02% compare to its pairs and should correct upwards.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases...

Stats
Объем за сегодня	7 909
Средний объем	46 933
Рыночная капитализация	66.24M
EPS	$-1.150 ( Q1 \| 2024-03-31 )
Дата следующего отчета о доходах	( $-0.960 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.690 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0780 (1.21%)

AADI -8.24%

ABCL 1.28%

ABCM 0.04%

ABEO -3.32%

ABIO -1.68%

ABOS 3.74%

ABSI 3.74%

ABUS -0.82%

ABVX -3.00%

ACAD -0.32%

ACER -17.95%

ACET -9.15%

ACGN 1.29%

ACHL -2.48%

ACHV 3.66%

ACIU -1.50%

ACLX -0.44%

ACRV -5.28%

ACST -1.63%

ACXP 3.92%

ADAG 6.07%

ADAP -3.42%

ADGI 0.87%

ADIL -1.75%

ADMA -1.95%

ADPT 0.74%

ADTX -2.78%

ADVM 0.87%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -2.97%

AGEN -3.83%

AGIO -2.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 4.30%

AKRO -2.55%

AKTX 0.35%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.11%

ALGS -1.52%

ALKS 1.65%

ALLK -11.06%

ALLO -4.17%

ALLR -0.82%

ALNA 3.16%

ALNY 2.35%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -14.30%

ALVR -0.76%

ALXN 0.00%

ALXO -14.23%

ALZN 4.02%

AMRN -2.51%

AMTI -3.13%

ANAB 1.01%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 1.97%

ANPC -3.15%

APGE 0.71%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 0.87%

APLT -1.13%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 0.62%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -6.43%

ARDS -12.13%

ARDX 0.67%

ARGX -0.59%

ARNA 0.00%

ARPO -0.90%

ARQT -2.97%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.72%

ARWR -1.86%

ASLN -3.44%

ASMB -4.22%

ASND -2.14%

ATAI -4.81%

ATHA 6.89%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 4.85%

ATRA -3.60%

ATXI -2.78%

ATXS -1.11%

AUPH -1.17%

AURA 4.11%

AUTL -3.16%

AVBP -5.03%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE -1.03%

AVTX -3.74%

AVXL -5.43%

AXLA 0.00%

AXSM -1.47%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.75%

BCAB -5.88%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.81%

BCTX 12.37%

BCTXW 13.02%

BCYC 0.70%

BDRX -4.01%

BDTX -0.64%

BEAM 2.19%

BFRA -2.91%

BGNE -2.25%

BIOR -4.69%

BIVI 2.79%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.78%

BLTE -1.13%

BLU 0.03%

BLUE -2.38%

BMEA -14.29%

BMRN 0.53%

BNOX 6.15%

BNTC -3.06%

BNTX -1.71%

BOLD -9.93%

BOLT -0.05%

BPMC -1.68%

BPTH -1.43%

BPTS -13.47%

BRNS -0.37%

BRTX -4.29%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.35%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -0.86%

CARA -3.23%

CARM 6.96%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.65%

CCXI 0.00%

CDAK 0.00%

CDIO -2.99%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -1.68%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.58%

CDXS 8.28%

CELC -3.70%

CELU 1.33%

CELUW 11.80%

CERC -1.68%

CERE -1.61%

CERO -6.66%

CEROW -10.18%

CFRX -27.95%

CGEM -0.55%

CGEN -3.31%

CGON -1.62%

CGTX -3.98%

CHMA -6.00%

CHRS 4.13%

CINC 0.00%

CING 2.22%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.94%

CLGN 0.00%

CLLS -3.11%

CLNN -2.72%

CLNNW 0.00%

CLRB 6.64%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 4.03%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.38%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 0.56%

CNTB -0.75%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.55%

COYA 1.16%

CPRX -1.88%

CRBP -0.83%

CRBU -7.10%

CRDF 0.67%

CRGX -0.67%

CRIS -1.59%

CRNX -6.11%

CRSP 0.05%

CRTX 2.63%

CRVO -3.95%

CRVS 0.28%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -3.72%

CTNM 1.98%

CTXR -1.40%

CUE -3.11%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.76%

CYTO 0.00%

DARE 2.94%

DAWN -0.82%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.88%

DNLI -2.23%

DNTH -6.46%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL 0.63%

DYAI 9.68%

EARS -1.77%

EDIT -3.02%

EDSA 4.09%

EFTR 4.10%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.40%

ELEV -2.49%

ELOX 10.77%

ELTX -5.15%

ELVN -1.54%

ELYM 5.86%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA -0.73%

ENTO -4.97%

ENTX -1.34%

ENVB 4.81%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS 1.20%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.51%

ETON 2.90%

ETTX 0.00%

EVAX -0.71%

EVGN 5.02%

EVLO 0.00%

EWTX -0.89%

EXAI -0.94%

EXEL 0.52%

EYEG -0.69%

EYEN 0.00%

EYPT 0.85%

FATE -11.96%

FBIO 0.59%

FBIOP 0.87%

FBLG -6.49%

FBRX -0.02%

FDMT -5.62%

FENC -2.52%

FGEN -9.83%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.62%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.49%

FULC 1.17%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -3.08%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -2.54%

GHRS -3.72%

GLMD -4.09%

GLPG -1.68%

GLSI 5.01%

GLTO -3.31%

GLUE -3.69%

GLYC -11.89%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.65%

GNPX -3.43%

GNTA 3.94%

GOSS -9.45%

GOVX -1.36%

GOVXW 10.89%

GPCR -7.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.44%

GRTX -1.66%

GTHX 1.36%

GUTS 0.35%

GXGXW 41.67%

GYRE -4.99%

HALO -1.65%

HARP 0.09%

HCWB -6.13%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -1.30%

HOOK 1.97%

HOTH -1.65%

HOWL 0.85%

HRMY 3.54%

HRTX 8.20%

HSTO 0.00%

HUMA 1.22%

HUMAW -6.26%

IBRX -6.74%

ICCC -3.10%

ICPT 0.21%

ICU 15.49%

ICUCW 10.23%

ICVX -0.91%

IDRA -23.04%

IDYA -3.23%

IFRX -2.78%

IGMS -1.61%

IKNA -1.19%

IKT -9.93%

IMAB 0.00%

IMCR -3.36%

IMGN 0.02%

IMGO 0.00%

IMMP 5.13%

IMMX -6.90%

IMNM 3.64%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.33%

IMTXW 6.00%

IMUX 2.31%

IMV 0.00%

IMVT -3.41%

INAB -0.72%

INBX -2.78%

INCY -2.25%

INDP 7.34%

INFI -52.38%

INKT 1.69%

INM 3.32%

INMB 4.03%

INO 2.99%

INSM -1.08%

INTS -1.96%

INVA 0.43%

INZY 1.72%

IOBT -10.24%

IONS 1.12%

IOVA -2.78%

IPA 3.00%

IPHA 5.08%

IPSC -2.73%

IRON -2.67%

ISEE 0.38%

ITOS 1.98%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.05%

JANX -4.87%

JAZZ -1.05%

JNCE 0.00%

JSPR -2.07%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.20%

KDNY 0.22%

KMPH -0.34%

KNSA -2.03%

KNTE -0.38%

KOD -8.10%

KPRX -4.08%

KPTI -8.46%

KRBP -10.00%

KRON 1.58%

KROS -0.53%

KRRO -2.42%

KRTX 0.03%

KRYS 0.19%

KTRA 14.78%

KTTA -0.65%

KTTAW 0.92%

KURA 0.83%

KYMR -3.44%

KYTX -4.13%

KZIA 2.36%

KZR -1.48%

LABP 0.57%

LBPH -0.32%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.71%

LENZ -3.17%

LEXX -1.54%

LEXXW -14.63%

LGND -1.21%

LGNDV 0.00%

LGVN -10.16%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA -0.16%

LRMR 0.21%

LSTA -1.68%

LTRN 5.74%

LUMO 1.79%

LVTX -4.12%

LXEO -8.68%

LXRX -1.78%

LYEL -35.05%

LYRA 4.03%

MACK 0.10%

MBIO -11.00%

MBRX -1.43%

MCRB 2.58%

MDGL -2.24%

MDNA -13.16%

MDWD 3.46%

MDXG -1.69%

MEIP 0.00%

MESO -1.78%

MGNX -5.24%

MGTA -7.74%

MGTX -0.71%

MGX 2.14%

MIRM 0.33%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -5.84%

MLECW 2.31%

MLND -5.36%

MLTX -0.03%

MLYS -6.49%

MNKD -0.95%

MNMD 2.83%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.42%

MORF -3.21%

MREO 0.14%

MRKR -0.43%

MRNA -9.41%

MRNS -6.62%

MRSN -2.86%

MRTX -0.17%

MRUS -0.27%

MRVI -0.07%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS 0.00%

NAMSW -0.42%

NAUT 0.89%

NBRV 0.71%

NBSE -1.56%

NBTX 8.40%

NCNA 0.36%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.31%

NKGN 10.91%

NKGNW -20.00%

NKTR 3.74%

NKTX -3.52%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.94%

NMTR -42.97%

NOVN -24.84%

NRBO 14.44%

NRIX -0.91%

NRSN -2.74%

NRSNW 0.00%

NRXP -7.43%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.62%

NTEC -12.45%

NTHI 0.00%

NTLA -5.54%

NTRBW -31.07%

NUVL -1.41%

NVAX -7.00%

NVCT -8.37%

NVIV -34.28%

NXTC -5.29%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO 1.90%

OBSV 0.00%

OCEA -2.82%

OCGN 8.51%

OCS -1.00%

OCUL 0.76%

OCUP 1.31%

ODT -4.27%

OKYO 1.72%

OLMA -5.37%

OMER -2.57%

OMGA -1.24%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 1.33%

OPNT 0.00%

OPT -4.00%

ORGS -0.69%

ORIC -3.56%

ORMP 18.08%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.53%

OVID 0.30%

OYST 0.00%

PALI -0.22%

PASG 0.00%

PBLA -7.50%

PBM -4.81%

PBYI 2.70%

PCSA -1.93%

PCVX -0.13%

PDSB -6.94%

PEPG 1.37%

PGEN -7.19%

PHAR 2.19%

PHAS 0.00%

PHAT -0.87%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.38%

PLUR 7.39%

PMN -5.55%

PMVP -3.27%

PNT 0.16%

PPBT -6.87%

PRAX 7.00%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK -0.90%

PRQR 1.20%

PRTA -3.08%

PRTC 0.62%

PRTG 0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.80%

PSTX -3.29%

PTCT -0.74%

PTE -0.82%

PTGX -1.07%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 3.27%

QLGN -2.78%

QNCX 5.70%

QNRX -0.08%

QSI -32.46%

QSIAW -24.94%

QTTB 1.83%

QURE -1.12%

RAIN -1.63%

RANI 4.81%

RAPT -2.27%

RARE 2.23%

RCKT -10.02%

REGN -0.39%

RENB -3.11%

REPL -2.38%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.85%

RGNX -6.74%

RIGL -6.24%

RLAY -5.04%

RLMD 0.00%

RLYB -4.36%

RNA 1.85%

RNAC -4.74%

RNAZ -0.65%

RNXT 1.79%

ROIV -1.89%

ROIVW 4.56%

RPHM -1.86%

RPRX -0.69%

RPTX -0.88%

RUBY 2.70%

RVLP -32.05%

RVMD -0.80%

RVMDW -29.90%

RVNC -0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.34%

RYTM -6.41%

RYZB 0.02%

RZLT 1.68%

SABS -1.37%

SABSW -11.81%

SAGE 0.09%

SANA -2.95%

SAVA -2.28%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 9.60%

SCPS 0.00%

SEEL -4.94%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.43%

SGMT -5.32%

SGTX -2.56%

SIOX 22.63%

SLDB -2.93%

SLGL 5.23%

SLN -7.24%

SLNO 0.55%

SLRX -0.81%

SLS -2.56%

SMMT -3.12%

SNDX 2.97%

SNGX 2.08%

SNPX 0.23%

SONN -2.15%

SPPI -0.49%

SPRB -1.36%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.21%

SRRA 0.00%

SRRK -2.11%

SRZN -2.45%

STAB 0.00%

STOK -7.24%

STRO -2.68%

STSA 0.00%

STTK 6.47%

SURF -0.93%

SVRA -1.84%

SWTX -0.47%

SYBX 1.29%

SYRS -2.24%

TALS -0.73%

TARA -7.38%

TARS -2.49%

TBPH 0.71%

TCBP 9.58%

TCDA 0.00%

TCON -1.00%

TCRR 0.00%

TCRT -1.75%

TCRX 3.56%

TECH -0.86%

TENX -0.32%

TERN -8.26%

TFFP -7.61%

TGTX -6.98%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -6.72%

TNGX -3.46%

TNXP -7.99%

TNYA -4.38%

TPST 5.78%

TRDA -4.77%

TRVI 2.68%

TRVN 0.68%

TSHA -19.03%

TSVT -4.26%

TTNP -6.05%

TVTX 3.20%

TYRA -6.83%

UBX -2.13%

UNCY -4.88%

URGN 2.22%

UTHR -0.11%

VACC 11.36%

VALN -6.70%

VAXX 106.25%

VBIV 0.91%

VBLT -8.77%

VCEL 0.98%

VCNX 8.64%

VCYT -1.01%

VERA -5.05%

VERU 2.59%

VERV -2.78%

VIGL -1.08%

VINC 2.93%

VIR -1.19%

VIRI -5.66%

VIRX 3.98%

VKTX -1.69%

VLON -13.04%

VNDA -4.07%

VOR -6.05%

VRCA 0.50%

VRDN -4.23%

VRNA -1.70%

VRPX 1.02%

VRTX 0.08%

VSTM 4.25%

VTGN -1.20%

VTVT 0.39%

VTYX -3.14%

VXRT -1.85%

VYGR -0.83%

VYNE -6.36%

VYNT 7.78%

WINT -2.72%

WVE -8.81%

XBIO 1.03%

XBIT 6.72%

XCUR 3.13%

XENE -1.77%

XERS 4.52%

XFOR 4.69%

XLO 4.42%

XLRN 0.00%

XNCR 0.26%

XOMA -8.67%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.55%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.73%

ZNTL -2.02%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Chudnovsky Yekaterina	Buy	1 032 702	Pre-Funded Common Stock Purchase Warrant
2024-02-01	Piekos Brian	Buy	43 225	Stock Option (right to buy)
2024-02-01	Connelly Robert	Buy	225 137	Stock Option (right to buy)
2024-02-01	Haqq Christopher	Buy	28 200	Stock Option (right to buy)
2024-02-01	Demuth Peter	Buy	29 800	Stock Option (right to buy)

INSIDER POWER
100.00
Last 6 transactions
Buy: 1 359 406 \| Sell: 0

Корреляция (AI algo v.1.1b): Undervalued: 0.02% $6.45 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

Elicio Therapeutics, Inc. Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Elicio Therapeutics, Inc. Финансовые показатели

Annual	2022
Выручка:	$0
Валовая прибыль:	$0 (0.00 %)
EPS:	$-88.84

FY	2022
Выручка:	$0
Валовая прибыль:	$0 (0.00 %)
EPS:	$-88.84

FY	2020
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-1.930

FY	2019
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-1.505

Financial Reports:

No articles found.

Elicio Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. The company\'s lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers. It is also developing ELI-004, an AMP-modified CpG adjuvant, a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers; ELI-005, a vaccine candidate for the prevention of COVID-19; ELI-011 for the treatment of hematological cancers; and ELI-012, a mKRAS TCR T cell AMP-lifier designs to use in combination with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company is headquartered in Boston, Massachusetts.